BSX vs ISRG
BSX and ISRG side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BSXBOSTON SCIENTIFIC CORPORATION | ISRGIntuitive Surgical, Inc. |
|---|---|---|
| Market cap | $71.48B | $133.84B |
| P/E (TTM) | 20.0 | 43.4 |
| P/B | 2.87 | 7.37 |
| P/S | 3.6x | 13.3x |
| Revenue | $21.00B(TTM) | $11.03B(TTM) |
| Revenue growth (YoY) | 19.9% | 20.5% |
| Net income | $3.67B(TTM) | $3.14B(TTM) |
| Earnings growth (YoY) | 56.7% | 23.0% |
| EPS, diluted | $2.47(TTM) | $8.72(TTM) |
| EBIT margin | 18.0% | 29.3% |
| ROE | 11.6% | 15.7% |
| ROIC | 10.0% | — |
| Piotroski F | 8/9 | — |
| 1y total return | -52.1% | -19.2% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: BSX vs ISRG
| Metric | BSX | ISRG |
|---|---|---|
| End value | $25.2K | $54.5K |
| Total return | +152.1% | +444.5% |
| CAGR | +9.4% | +17.8% |
| Volatility | 27.4% | 32.6% |
| Sharpe | 0.32 | 0.55 |
| Sortino | 0.44 | 0.79 |
| Max drawdown | -60.6% | -49.9% |
Based on 2600 common trading days, 2016-04-06 → 2026-08-07 · risk-free 3.87% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)